Showing items 1–100
Methods for the treatment of disease using immunoglobulins having fc regions with altered…
Grant US-11787871-B2
United States of America
Optimized antibodies that target CD19
Grant US-11618788-B2
United States of America
B7-H3 directed antibody drug conjugates
Grant US-11591400-B2
United States of America
Compositions and methods for treating IgE-mediated disorders
Grant US-11566080-B2
United States of America
Methods and compositions for inhibiting CD32B expressing cells
Grant US-11447552-B2
United States of America
Methods and compositions for inhibiting CD32B expressing cells
Grant US-11434295-B2
United States of America
Bispecific molecules that are immunoreactive with immune effector cells that express an…
Grant US-11421031-B2
United States of America
Heterodimeric Fc variants
Grant US-11401348-B2
United States of America
Bi-specific monovalent Fc diabodies that are capable of binding CD32B and CD79b and uses…
Grant US-11384149-B2
United States of America
Methods and compositions for inhibiting CD32B expressing cells in IGG4-related diseases
Grant US-11365256-B2
United States of America
CTLA4-IG immunoadhesins
Grant US-11352412-B2
United States of America
Covalent diabodies and uses thereof
Grant US-11254748-B2
United States of America
Covalent diabodies and uses thereof
Grant US-11254747-B2
United States of America
CTLA4-Ig immunoadhesins
Grant US-11254727-B2
United States of America
Fc variants with altered binding to FcRn
Grant US-11198739-B2
United States of America
FcγRIIB-specific antibodies and methods of use thereof
Grant US-11098125-B2
United States of America
HER2/neu-specific antibodies and methods of using same
Grant US-11028183-B2
United States of America
B7-H3 binding molecules, antibody drug conjugates thereof and methods of use thereof
Grant US-10961311-B2
United States of America
Immunoglobulins and variants directed against pathogenic microbes
Grant US-10941193-B2
United States of America
Immunoglobulins and variants directed against pathogenic microbes
Grant US-10913791-B2
United States of America
Bi-specific monovalent diabodies that are capable of binding to gpA33 and CD3, and uses…
Grant US-10858430-B2
United States of America
Bi-specific monovalent diabodies that are capable of binding CD123 and CD3, and uses…
Grant US-10787521-B2
United States of America
Bispecific molecules that are immunoreactive with immune effector cells that express an…
Grant US-10730947-B2
United States of America
Antibodies reactive with B7-H3 and users thereof
Grant US-10730945-B2
United States of America
Bispecific molecules comprising an HIV-1 envelope targeting arm
Grant US-10717778-B2
United States of America
Methods for the treatment of disease using immunoglobulins having Fc regions with altered…
Grant US-10711069-B2
United States of America
Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereof
Grant US-10683364-B2
United States of America
Optimized antibodies that target CD19
Grant US-10626182-B2
United States of America
Universal biosensor system for analyte detection
Grant US-10613083-B2
United States of America
Fc variants with increased affinity for FcγRIIc
Grant US-10584176-B2
United States of America
BCR-complex-specific antibodies and methods of using same
Grant US-10479831-B2
United States of America
Immunoglobulins and variants directed against pathogenic microbes
Grant US-10457723-B2
United States of America
Bi-specific monovalent Fc diabodies that are capable of binding CD32B and CD79b and uses…
Grant US-10344092-B2
United States of America
Fc variants with altered binding to FcRn
Grant US-10336818-B2
United States of America
Optimized Fc variants and methods for their generation
Grant US-10183999-B2
United States of America
Optimized Fc variants and methods for their generation
Grant US-10184000-B2
United States of America
CTLA4-Ig immunoadhesins
Grant US-10155800-B2
United States of America
HER2/neu-specific antibodies and methods of using same
Grant US-10131713-B2
United States of America
Fc variants with increased affinity for FcyRIIc
Grant US-10113001-B2
United States of America
FcγRIIB-specific antibodies and methods of use thereof
Grant US-10100116-B2
United States of America
Covalent diabodies and uses thereof
Grant US-10093738-B2
United States of America
Covalent diabodies and uses thereof
Grant US-10093739-B2
United States of America
Immunoglobulins and variants directed against pathogenic microbes
Grant US-9988439-B2
United States of America
Covalent diabodies and uses thereof
Grant US-9963510-B2
United States of America
Bi-specific monovalent diabodies that are capable of binding to gpA33 and CD3, and uses…
Grant US-9932400-B2
United States of America
Methods and compositions for inhibiting CD32B expressing cells
Grant US-9914778-B2
United States of America
Bispecific molecules that are immunoreactive with immune effector cells that express an…
Grant US-9908938-B2
United States of America
Methods and compositions for inhibiting CD32b expressing cells
Grant US-9902773-B2
United States of America
Antibodies reactive with B7-H3 and uses thereof
Grant US-9896508-B2
United States of America
Covalently-associated diabody complexes that possess charged coil domains and that are…
Grant US-9889197-B2
United States of America
Bi-specific monovalent diabodies that are capable of binding CD123 and CD3, and uses…
Grant US-9822181-B2
United States of America
Fc variants with altered binding to FcRn
Grant US-9803023-B2
United States of America
Optimized antibodies that target CD19
Grant US-9803020-B2
United States of America
Combination of FcγRIIB-specific antibodies and CD20-specific antibodies and methods of…
Grant US-9737599-B2
United States of America
Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereof
Grant US-9714296-B2
United States of America
Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereof
Grant US-9714295-B2
United States of America
Optimized Fc variants and methods for their generation
Grant US-9714282-B2
United States of America
Methods for the treatment of disease using immunoglobulins having Fc Regions with altered…
Grant US-9708408-B2
United States of America
BCR-complex-specific antibodies and methods of using same
Grant US-9695236-B2
United States of America
Compositions and methods for treating IgE-mediated disorders
Grant US-9617348-B2
United States of America
Optimized anti-CD30 antibodies
Grant US-9574006-B2
United States of America
Compositions and methods for treating IgE-mediated disorders
Grant US-9540451-B2
United States of America
Compositions and methods for simultaneous bivalent and monovalent co-engagement of…
Grant US-9493578-B2
United States of America
Bispecific molecules that are immunoreactive with immune effector cells of a companion…
Grant US-9487587-B2
United States of America
Antibody variants with enhanced complement activity
Grant US-9475881-B2
United States of America
HER2/neu-specific antibodies and methods of using same
Grant US-9469692-B2
United States of America
Antibodies reactive with B7-H3 and uses thereof
Grant US-9441049-B2
United States of America
Immunoglobulins and variants directed against pathogenic microbes
Grant US-9416171-B2
United States of America
Methods and compositions for inhibiting CD32B expressing cells
Grant US-9394366-B2
United States of America
Deimmunized serum-binding domains and their use in extending serum half-life
Grant US-9376495-B2
United States of America
CTLA4-Ig immunoadhesins
Grant US-9371397-B2
United States of America
Optimized FC variants and methods for their generation
Grant US-9353187-B2
United States of America
Covalent diabodies and uses thereof
Grant US-9296816-B2
United States of America
Covalent diabodies and uses thereof
Grant US-9284375-B2
United States of America
Compositions and methods for treating IgE-mediated disorders
Grant US-9266966-B2
United States of America
Methods and compositions for inhibiting CD32b expressing cells
Grant US-9260523-B2
United States of America
HER2/neu-specific antibodies and methods of using the same
Grant US-9243069-B2
United States of America
Compositions and methods for treating IgE-mediated disorders
Grant US-9221916-B2
United States of America
Fc variants with altered binding to FcRn
Grant US-9200079-B2
United States of America
Optimized Fc variants and methods for their generation
Grant US-9193798-B2
United States of America
Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereof
Grant US-9150656-B2
United States of America
Fc region-containing polypeptides that exhibit improved effector function due to…
Grant US-9096877-B2
United States of America
Methods and compositions for inhibiting CD32B expressing cells
Grant US-9079960-B2
United States of America
Compositions and methods for treating IgE-mediated disorders
Grant US-9062117-B2
United States of America
Modified FC molecules
Grant US-9040041-B2
United States of America
Optimized antibodies that target HM1.24
Grant US-9040042-B2
United States of America
Identification and engineering of antibodies with variant FC regions and methods of using…
Grant US-9028815-B2
United States of America
BCR-complex-specific antibodies and methods of using same
Grant US-8993730-B2
United States of America
FcγRIIB specific antibodies and methods of use thereof
Grant US-8968730-B2
United States of America
Identification and engineering of antibodies with variant Fc regions and methods of using…
Grant US-8951517-B2
United States of America
FcγRIIB specific antibodies and methods of use thereof
Grant US-8946387-B2
United States of America
Fc variants with altered binding to FcRn
Grant US-8883973-B2
United States of America
Immunoglobulins insertions, deletions, and substitutions
Grant US-8883147-B2
United States of America
Optimized Fc variants and methods for their generation
Grant US-8858937-B2
United States of America
Fc variants with altered binding to FcRn
Grant US-8852586-B2
United States of America
Optimized Fc variants and methods for their generation
Grant US-8809503-B2
United States of America
Fc variants with altered binding to FcRn
Grant US-8802820-B2
United States of America
HER2/neu-specific antibodies and methods of using same
Grant US-8802093-B2
United States of America
Antibodies reactive with B7-H3 and uses thereof
Grant US-8802091-B2
United States of America
Showing items 1–100